ReviewViruses2022

Laboratory-Based SARS-CoV-2 Receptor Binding Domain Serologic Assays Perform with Equivalent Sensitivity and Specificity to Commercial FDA-EUA Approved Tests.

Mary Nehring et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.